Marcel·lí Carbó

711 total citations
22 papers, 517 citations indexed

About

Marcel·lí Carbó is a scholar working on Toxicology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marcel·lí Carbó has authored 22 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 8 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marcel·lí Carbó's work include Forensic Toxicology and Drug Analysis (10 papers), Psychedelics and Drug Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Marcel·lí Carbó is often cited by papers focused on Forensic Toxicology and Drug Analysis (10 papers), Psychedelics and Drug Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Marcel·lí Carbó collaborates with scholars based in Spain, United States and Netherlands. Marcel·lí Carbó's co-authors include Rafael de la Torre, David Pubill, Elena Escubedo, Raúl López‐Arnau, Jorge Camarasa, José Martínez-Clemente, Jordi Segura, Magı́ Farré, Marta Torrens and Jordi Camı́ and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

Marcel·lí Carbó

21 papers receiving 502 citations

Peers

Marcel·lí Carbó
Jakub Wojcieszak Poland
Niels Bjerre Holm Denmark
Douwe de Boer Netherlands
Martin Jübner Germany
Merja A. Neukamm Germany
Kayla N. Ellefsen United States
Anders Just Pedersen Denmark
S. Geisshüsler Switzerland
Maurice Wilde Germany
Krishna C. Chimalakonda United States
Jakub Wojcieszak Poland
Marcel·lí Carbó
Citations per year, relative to Marcel·lí Carbó Marcel·lí Carbó (= 1×) peers Jakub Wojcieszak

Countries citing papers authored by Marcel·lí Carbó

Since Specialization
Citations

This map shows the geographic impact of Marcel·lí Carbó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel·lí Carbó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel·lí Carbó more than expected).

Fields of papers citing papers by Marcel·lí Carbó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel·lí Carbó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel·lí Carbó. The network helps show where Marcel·lí Carbó may publish in the future.

Co-authorship network of co-authors of Marcel·lí Carbó

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel·lí Carbó. A scholar is included among the top collaborators of Marcel·lí Carbó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel·lí Carbó. Marcel·lí Carbó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monfort, Núria, et al.. (2025). Pharmacokinetic profile of dexamethasone in urine and plasma after single and multiple oral administration: Relevance to doping controls. European Journal of Pharmaceutical Sciences. 217. 107405–107405.
2.
Castro‐Zavala, Adriana, Marina D. Reguilón, Marina Bellot, et al.. (2024). Sex differences in the effects of N‐ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression. British Journal of Pharmacology. 181(22). 4491–4513. 1 indexed citations
3.
López‐Arnau, Raúl, et al.. (2022). 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Frontiers in Psychiatry. 13. 990405–990405. 4 indexed citations
4.
Matabosch, Xavier, Marcel·lí Carbó, Clara Pérez‐Mañá, et al.. (2019). Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra‐articular administration. Drug Testing and Analysis. 11(11-12). 1589–1600. 12 indexed citations
5.
Olesti, Eulàlia, Ilario De Toma, Johannes G. Ramaekers, et al.. (2018). Metabolomics predicts the pharmacological profile of new psychoactive substances. Journal of Psychopharmacology. 33(3). 347–354. 23 indexed citations
6.
López‐Arnau, Raúl, et al.. (2015). Concentrations of MDPV in rat striatum correlate with the psychostimulant effect. Journal of Psychopharmacology. 29(11). 1209–1218. 43 indexed citations
7.
Martínez-Clemente, José, Raúl López‐Arnau, Marcel·lí Carbó, et al.. (2013). Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology. 229(2). 295–306. 67 indexed citations
8.
López‐Arnau, Raúl, José Martínez-Clemente, Marcel·lí Carbó, et al.. (2013). An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts”. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 45. 64–72. 48 indexed citations
9.
Yubero‐Lahoz, Samanta, Ricardo Pardo, Magı́ Farré, et al.. (2012). Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug. Drug Metabolism and Pharmacokinetics. 27(6). 605–613. 14 indexed citations
10.
Farré, Magı́, Samanta Yubero‐Lahoz, Marta Torrens, et al.. (2012). Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT). PLoS ONE. 7(10). e47599–e47599. 51 indexed citations
11.
Peiró, Ana M., Magı́ Farré, P. N. Roset, et al.. (2012). Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. Psychopharmacology. 225(4). 883–893. 36 indexed citations
12.
Yubero‐Lahoz, Samanta, Ricardo Pardo, Magı́ Farré, et al.. (2011). Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. Clinical Pharmacokinetics. 50(5). 319–329. 22 indexed citations
13.
14.
Andaluz, Anna, Xavier Moll, Rosario Abellán, et al.. (2008). Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs. The Veterinary Journal. 181(3). 299–304. 23 indexed citations
15.
Carbó, Marcel·lí, et al.. (2008). Antihistaminic effects of rupatadine and PKPD modelling. European Journal of Drug Metabolism and Pharmacokinetics. 33(2). 107–116. 11 indexed citations
16.
17.
18.
Barnett, Gene, Jordi Segura, Rafael de la Torre, & Marcel·lí Carbó. (1990). Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition. European Journal of Clinical Pharmacology. 39(1). 63–69. 13 indexed citations
19.
Carbó, Marcel·lí, et al.. (1989). Effect of quinolones on caffeine disposition. Clinical Pharmacology & Therapeutics. 45(3). 234–240. 45 indexed citations
20.
Sanz, Ferrán, et al.. (1988). Automatic determination of MEP patterns of molecules and its application to caffeine metabolism inhibitors. Journal of Molecular Structure THEOCHEM. 170. 171–180. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakub Wojcieszak Breakdown of academic impact, for papers by Niels Bjerre Holm Breakdown of academic impact, for papers by Douwe de Boer Breakdown of academic impact, for papers by Martin Jübner Breakdown of academic impact, for papers by Merja A. Neukamm Breakdown of academic impact, for papers by Kayla N. Ellefsen Breakdown of academic impact, for papers by Anders Just Pedersen Breakdown of academic impact, for papers by S. Geisshüsler Breakdown of academic impact, for papers by Maurice Wilde Breakdown of academic impact, for papers by Krishna C. Chimalakonda
Rankless by CCL
2026